Journey Medical Corp. (DERM)
3.30
-0.25
(-7.04%)
USD |
NASDAQ |
Nov 20, 15:51
Journey Medical Shareholders Equity (Quarterly) : 32.25M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 32.25M |
| June 30, 2026 | 32.11M |
| March 31, 2026 | 30.83M |
| December 31, 2025 | 31.85M |
| September 30, 2025 | 25.90M |
| June 30, 2025 | 19.25M |
| March 31, 2025 | 21.54M |
| December 31, 2024 | 20.07M |
| September 30, 2024 | 10.93M |
| June 30, 2024 | 11.30M |
| March 31, 2024 | 12.95M |
| December 31, 2023 | 20.35M |
| Date | Value |
|---|---|
| September 30, 2023 | 17.37M |
| June 30, 2023 | 0.005M |
| March 31, 2023 | 7.492M |
| December 31, 2022 | 16.98M |
| September 30, 2022 | 26.18M |
| June 30, 2022 | 34.80M |
| March 31, 2022 | 41.44M |
| December 31, 2021 | 42.04M |
| September 30, 2021 | -11.71M |
| June 30, 2021 | -0.792M |
| March 31, 2021 | |
| December 31, 2020 | 10.29M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Talphera, Inc. | 10.71M |
| Fortress Biotech, Inc. | 160.00M |
| Relmada Therapeutics, Inc. | 193.74M |
| Turn Therapeutics, Inc. | 5.692M |
| ANI Pharmaceuticals, Inc. | 637.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.85M |
| Total Liabilities (Quarterly) | 71.60M |
| Debt to Equity Ratio | 0.7945 |
| Current Ratio | 1.481 |
| Net Debt Paydown Yield | -0.04% |